Medical network - February 27 February 23, 2017, the ministry of human resources and social security website released the national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue (2017 edition) "(hereinafter referred to as: the national health insurance directory). Including step pharmaceutical and hengrui pharmaceutical, and a number of listed companies in hk pharmaceutical related products into this directory.
In the 2017 edition of the national health insurance directory, herbal supplement number more than expected, while the use of TCM injections, auxiliary medication has been curbed.
Eight years later medical insurance directory to adjust again
After the national health insurance directory release in 2009, at the beginning of 2017, people club department issued a national health insurance directory.
It is understood that in 2017 the list of drugs, western medicine and traditional part contains 2535 drugs, increased by 339 from the 2009 version of catalogue, rising by about 15.4%. Part of western medicine, 1297, proprietary Chinese medicine section 1238 (including ethnic medicine, 88). Chinese medicine yinpian part did not make an adjustment, still continue to use the provisions of the 2009 drugs directory.
"This time the new into the increased number of Chinese traditional medicine." Shi Lichen said, in addition, more local health supplement catalogue of products is also into the national health insurance directory.
In addition, through expert review synchronous identified 45 to negotiate drug, are of higher clinical value but relatively expensive, exclusive patent drugs. The next step is to confirm whether enterprises have after negotiating intentions, publish to the society plans to negotiate drug list and group negotiation according to related procedure.
People club department said, the catalog of 2017 drug is completely determined by expert evaluation, reflects the "fill a vacancy, selection, support innovation, encourage competition policy thinking, for medicine, children's medicine, innovative medicine of inductrial injury insurance, major disease treatment medicine and national medicine to consider and support.
People club department requirement, the provinces (autonomous regions and municipalities) should be released on July 31, 2017 local insurance of primary medical treatment, inductrial injury insurance and maternity insurance drug catalogue. Adjust the number of (including call in and out, adjust the limit to pay limits) shall not exceed 15% of the national class b drugs number.
The future will be monitored
It is worth mentioning that in the context of health care of fee, the use of the drug will be monitored in the future.
People club department requirement, establish and improve the service of medical treatment of insurance of primary medical treatment of intelligent monitoring and control system for monitoring analysis of drug use and social insurance system, the key monitoring dosage, expense and there may be more not rational use of medicines, monitoring results to the public in the proper manner. Give play to the role of pharmacists, motivate medical institutions to take effective measures to promote clinical rational drug use.
Learned, published in the national health insurance directory, including TCM injections and other drug use is limited.
ShuangHuangLian injection, for example, qing ling injection, lotus will injection, toxic heat ning injection, xi phlogistic flat injection, heartleaf houttuynia herb injection, phlegm heat injection limit level 2 and above all medical institutions to use.
From huatai securities analysis according to the report, the vast majority of heat-clearing and detoxifying, TCM injections and part of heart head blood-vessel HuaYao adjuvant were limited to level 2 above hospitals use, dosage of grassroots will be drastically reduced. "We expect to have the long-term adjuvant whole recession".
"Curative effect, can meet the demand of clinical pathway, rigid treatment prescription drugs can be in an impregnable position in the hospital health care specialist, and a growing number of adjuvant therapy drug will be out of the hospital." An analysis report from everbright securities. |
